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Staphylococcus aureus Bloodstream Infections in Older
Adults: Clinical Outcomes and Risk Factors for
In-Hospital Mortality
Cecilia Big, MD, and Preeti N. Malani, MD, MSJwz§
OBJECTIVES: To assess clinical outcomes and identify
risk factors for mortality in older adults with Staphylococ-
cus aureus bloodstream infection (SAB).
DESIGN: Retrospective review.
SETTING: University of Michigan Health System, Ann
Arbor.
PARTICIPANTS: All patients aged 80 and older with SAB
between January 2004 and July 2008.
MEASUREMENTS: Clinical data, including comorbid
conditions, SAB source, echocardiography results, Charl-
son Comorbidity Index, mortality (in-hospital and
6-month), and need for rehospitalization or chronic care
after discharge.
RESULTS: Seventy-six patients aged 80 and older (mean
85.5  4.2) with SAB were identified. Infection sources in-
cluded 14 (18.4%) vascular catheter associated, 16 (21.1%)
wound related, seven (9.2%) endocarditis, five (6.6%) in-
travascular, and 19 (25%) with unknown source; 46
(60.5%) patients had methicillin-resistant strains. Twenty-
two (28.9%) patients underwent surgery or device place-
ment within 30 days of developing SAB; 10 of these 22 had
SAB associated with surgical site infection (SSI). Twenty
two (28.9%) patients died in the hospital or were dis-
charged to hospice care; at least 43 (56.6%) patients died
within 6 months of presentation, and eight were lost to
follow-up. Unknown source of bacteremia (odds ratio 5
5.2, P 5.008) was independently associated with in-hospi-
tal death. Echocardiography was not pursued in 45% of
patients. Of surviving patients, 40 (74.1%) required skilled
care after discharge; eight (20%) required rehospitalization.
CONCLUSION: SAB was associated with high mortality
rates in patients aged 80 and older. The observed associ-
ation between SAB and SSI may direct preventive strategies
such as perioperative decolonization or antimicrobial pro-
phylaxis. Interventions to optimize clinical care practices in
elderly patients with SAB are essential given the associated
morbidity and mortality. J Am Geriatr Soc 58:300–305, 2010.
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The continued expansion of the geriatric population hasbeen associated with an increase in the number of
serious infections in older adults, including bloodstream
infections.1–4 Staphylococcus aureus bloodstream infection
(SAB) represents a significant burden in terms of morbidity
and mortality for older adults. Major risk factors associated
with the development of SAB includes the presence of
comorbid illnesses, such as congestive heart failure, chronic
kidney disease, and diabetes mellitus, and the use of medical
devices.5–10 The overall rates of SAB also increase with age,
as does mortality and attributable mortality, which is twice
as high in patients aged 65 and older as in younger pa-
tients.5,8,9
Recent work has suggested that the odds of death
within 6 months of SAB doubles for every decade increase
in age, and four of seven (57%) patients aged 80 older died
within 6 months.5 Based on these observations, it was de-
cided to specifically review the records of a different and
larger cohort of older patients (80) to better define risk
factors for mortality and identify potential areas for inter-
vention. The clinical course of SAB in the oldest old (80)
and risk factors for in-hospital mortality were examined.
METHODS
Overall Research Design
A retrospective study was conducted of all patients aged 80
and older with SAB who were admitted to the University of
Michigan Health System (UMHS) from January 2004 to
July 2008. Patients were identified by review of a database
maintained by the UMHS Microbiology Laboratory. SAB
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was defined as any blood culture positive for S. aureus with
an appropriate clinical presentation. Source of SAB infec-
tion was determined through review of the medical record
by an attending infectious diseases physician. Review of
infectious diseases consultation reports corroborated this
determination when applicable.
Baseline demographic information, clinical conditions,
and the source of infection were recorded. Physical and
occupational therapy reports were also reviewed to gather
limited information on mobility and level of independence
with activities of daily living (ADLs). In addition, comor-
bidity was measured using the Charlson weighted index of
comorbidity (WIC).11 In-hospital mortality included pa-
tients who died during their initial admission and those who
were discharged to hospice care and died within 1 to 2 days.
The institutional review board of the University of Mich-
igan Healthcare System approved this study.
Data Analysis
Univariate and bivariate analysis using t-tests for continu-
ous variables and chi-square or Fisher exact tests for cat-
egorical variables identified risk factors for death in patients
with SAB. A two-tailed P-value of .05 or less was consid-
ered statistically significant. Crude odds ratios (ORs) and
95% confidence intervals (CIs) were calculated for cate-
gorical variables. Crude ORs for continuous variables were
obtained using simple logistic regression. Variables that
were significant to a P-value of .20 and variables that had a
priori clinical significance were then analyzed using multi-
variate logistic regression modeling. All statistical analysis
was performed using SAS 9.1 (SAS Institute, Inc., Cary,
NC).
RESULTS
Patient Characteristics and Sources of Infection
Characteristics of patients with SAB are listed in Table 1.
Seventy-six patients aged 80 and older (mean 85.5  4.2,
range 80–99) were identified; 48 patients were male
(63.2%). Common medical comorbidities included hyper-
tension (71.1%), coronary artery disease (65.8%), and di-
abetes mellitus (34.2%).
The most common sources of SAB were wound related
(21.1%), osteomyelitis (21.1%), vascular catheter associ-
ated (18.4%), and endocarditis (9.2%); 25.0% of patients
had no clear source identified. Forty-six episodes of SAB
(60.5%) were secondary to methicillin-resistant S. aureus
(MRSA); the remaining 30 (39.5%) were secondary to
methicillin-sensitive S. aureus (MSSA). Six patients (8.6%)
developed Clostridium difficile infection during treatment
for SAB. Eight patients required rehospitalization after ini-
tial discharge; in four cases, the reason for rehospitalization
was recurrent SAB. Recurrent or relapsed SAB was ob-
served in five (6.6%) patients overall.
Of the 76 patients, 56 (73.7%) had SAB at the time of
admission. The remaining 20 (26.3%) patients acquired
SAB during hospitalization for another medical or surgical
issue. Mortality did not differ between these groups,
(P 5.49). Sixty-nine patients (90.8%) received an initial
antimicrobial course that appropriately covered the infect-
ing organism: MSSA or MRSA. Of the portion who re-
ceived treatment with vancomycin, all achieved trough
levels that measured 10 mg/mL or greater within three to
four doses. Incorrect antimicrobial selection was not asso-
ciated with mortality in this cohort; only one of the seven
patients who did not receive appropriate initial therapy died
in the hospital (P 5.42).
Association with Devices and Recent Surgery
Twenty patients had central vascular catheters (n 5 14) or
cardiac devices (n 5 6) in place at the time SAB developed.
All 14 central catheters were removed or changed within 1
to 3 days from the initial identification of positive blood
cultures. Four patients with cardiac devices did not have the
devices removed. Two patients with pacemakers were tran-
sitioned to hospice care because of a poor overall prognosis.
Two others with automatic implantable cardioverter
defibrillators received intravenous antibiotic therapy in an
attempt to suppress infection. Both experienced relapse of
SAB; one died during his second episode of infection, and
the other was lost to follow-up at 6 months.
Table 1. Underlying Conditions and Clinical Character-
istics for 76 Patients Aged 80 with Staphylococcus
aureus Bloodstream
Characteristic Value
Age, mean  SD 85.5  4
Male, n (%) 48 (63.2)
Comorbidities, n (%)
Hypertension 54 (71.1)
Coronary artery disease 50 (65.8)
Congestive heart failure 27 (35.6)
Diabetes mellitus 26 (34.2)




Hospitalization within past month, n (%) 37 (48.7)
Surgery or device placement within past 30 days, n (%) 22 (31.4)
Enteral feeding, n (%) 13 (17.1)
Charlson weighted index score, mean  SD 3.2  2.3
Methicillin-resistant Staphylococcus aureus, n (%) 46 (60.5)
Methicillin-sensitive Staphylococcus aureus, n (%) 30 (39.5)
Clostridium difficile infection, n (%) 6 (8.6)
No echocardiogram obtained, n (%) 34 (44.7)
Source of infection, n (%)
Vascular catheter associated 14 (18.4)
Wound related 16 (21.1)
Osteomyelitis (bone or joint) 16 (21.1)
Endocarditis 7 (9.2)
Intravascular infection 5 (6.6)
Respiratory tract 6 (7.9)
Genitourinary tract 3 (3.9)
Source unknown 19 (25)
Other 4 (5.3)
Neither transesophageal or transthoracic echo.
SD 5 standard deviation.
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Twenty-two patients (31.4%) underwent surgery or
placement of permanent medical devices during the 30 days
before SAB; in 10 (45.4%) of the 22, the source of SAB
appeared to be associated with the surgical procedure.12
Specific procedures included coronary artery bypass graft-
ing (n 5 2), lumbar laminectomy (n 5 3), hip arthroplasty
(n 5 1), prostatectomy (n 5 1), and upper extremity dialysis
graft placement (n 5 1) (Table 2). Seven of the 10 (70.0%)
patients with SSI associated SAB died within 6 months of
presentation.
Pre- and Posthospitalization Living Situation
Of the 76 patients, 46 (60.5%) lived in the community and
eight (10.5%) in an assisted living facility before admission.
The remaining 22 (28.9%) were admitted from an extended
care setting, where they were receiving chronic or subacute
care. Of the 46 patients who lived in the community before
developing SAB, 35 survived to discharge; 21 of the 35
(60.0%) were discharged to an extended care facility for
subacute rehabilitation. For all patients, the need for sub-
acute rehabilitation was slightly higher, with 40 (74.1%) of
54 patients who survived hospitalization requiring such
care after discharge. Primary reasons for subacute care in-
cluded impaired mobility, poor nutrition, wound care, and
the need for extended courses of parenteral antimicrobial
therapy.
Limited information on patients’ mobility was col-
lected through review of inpatient physical and occupa-
tional therapy assessments. Of the 54 survivors, 41 (75.9%)
had a level of independence with ADLs at discharge similar
to that at their pre-illness baseline. The other 13 (24.1%)
had a decline in functional status and mobility. At baseline,
all 13 of these patients were independent with ADLs and
able to ambulate unassisted before admission, but upon
discharge, these individuals were bedbound or required
maximal assistance to transfer from bed to wheelchair.
No association was observed between baseline functional
status (independent vs need for assistance with ADLs) and
in-hospital mortality (P 5.45).
Table 2. Patients with Staphylococcus aureus Bacteremia (SAB) Associated with Surgical Site Infections (N 5 10)





Detection of SAB Treatment and Outcome
83/F Revision of arteriovenous
graft
Graft infection MSSA 4 weeks Died of sepsis before completing planned 6-week
course of IV vancomycin
87/M Prostatectomy Paraspinal abscess L4-L5,
psoas abscess MRSA





4 weeks Catheter retained, patient treated with 2-week course
of IV vancomycin followed by oral trimethoprim and
sulfamethoxazole for chronic suppression; patient
transitioned to hospice care because of advanced
dementia and died soon afterward
85/F Left hip arthroplasty Prosthetic joint infection MRSA 4 weeks Incision and drainage of hip, removal of prosthesis,
placement of spacer along with IV vancomycin;
mechanical fall and development of hemarthrosis
complicated course; patient died of MRSA sepsis
before completing planned 6-week course of IV
therapy




1 week Patient treated with 8-week course of vancomycin
and quinupristin/dalfopristin along with operative
debridement and flap coverage of sternal wound;
remained on chronic suppression with oral
trimethoprim/sulfamethoxazole




3 weeks Patient treated with 4 weeks of IV cefazolin, local
wound care; lost to follow-up




2 weeks Infection successfully treated after multiple operative
debridements and 6 weeks of IV cefazolin
83/M Lumbar laminectomy
L3-L4, L4-L5
Lumbar wound MRSA 2 weeks Developed postoperative sepsis associated with
lumbar wound; died within 24 hours of the infection
being identified, before operative drainage





3 weeks Infection treated with IV vancomycin; died from




with laminectomy wound; SAB
resulted in prosthetic aortic
valve endocarditis MRSA
2 weeks Laminectomy wound treated with multiple operative
debridements to drain spinal abscess along with IV
vancomycin; died with home hospice care secondary
to congestive heart failure related to destruction of
prosthetic aortic value
MSSA 5 methicillin-sensitive Staphylococcus aureus; IV 5 intravenous; MRSA 5 methicillin-resistant Staphylococcus aureus.
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Risk Factors for Mortality
Twenty-two of the 76 patients (28.9%) died in the hospital
or were discharged home to hospice care and died within a
few days. Bivariate analysis identified several patient char-
acteristics associated with in-hospital mortality, including
unknown source of bacteremia, lack of echocardiography
evaluation, acute renal insufficiency, and high Charlson
WIC (Table 3). By 6 months after initial presentation, an
additional 21 patients died, so least 43 of 76 patients
(56.6%) died; eight patients were lost to follow-up.
Unknown cause of infection remained independently
associated with in-hospital mortality based on multivariate
analysis, (adjusted OR 5 3.7, P 5.05) (Table 3). Patients
with unknown cause of infection had a shorter duration of
bacteremia than patients with an identifiable source
(1.4  0.8 days vs 4.1  6.0 days, P 5.05). Of the 19 pa-
tients with unknown cause of BSI, 11 died in the hospital or
within a few days of being discharged to hospice care. An-
other three patients died between discharge and 6 months;
only five (26.3%) remained alive at 6 months.
DISCUSSION
The preceding results provide further evidence that SAB
results in substantial mortality in older adults. This patient
population experienced 28.9% in-hospital and at least
56.6% 6-month mortality. Risk factors for death included
unknown source of bacteremia, lack of echocardiography
evaluation, acute renal insufficiency, and high Charlson
WIC (Table 3). Unknown source of infection remained in-
dependently associated with in-hospital mortality on mul-
tivariable analysis (Table 4).
The reasons for the association between unknown
cause of bacteremia and in-hospital mortality remains un-
clear. One possible explanation is that extensive diagnostic
efforts to identify a source were not pursued, and therefore
a source was not identified. Review of patient records sug-
gests that this was the case for some of the patients with
unknown source because clinicians caring for these indi-
viduals documented that the overall prognosis was poor.
Several patients with unknown source of infection died
soon after admission or were quickly discharged to hospice
care. Review of the medical chart suggests that aggressive
medical examination was not pursued in part because of a
presumed poor prognosis. The duration of bacteremia was
shorter in patients with unknown source than in patients
with an identifiable source (1.4  0.8 days vs 4.1  6.0
days, P 5.05). This finding probably reflects that several
patients with unknown source died soon after admission or
were discharged to hospice careFso these patients did not
have an opportunity to have extended bacteremia.
Of the 19 patients with unknown source, 14 did not
have echocardiography evaluation. The lack of echocardio-
graphy may have confounded these results, because several
patients with unknown source could have had occult endo-
carditis, an infection associated with higher mortality than
simple SAB, particularly in older adults.13,14 Ten (52.6%)
of the 19 patients with unknown source were community
Table 3. Bivariate Analysis of the Effect of Patient Characteristics on In-Hospital Mortality from Staphylococcus aureus







(95% Confidence Interval) P-Value
Age, mean  SD 85.7  4.2 85.1  4.1 1.0 (0.85–1.1) .58
Charlson index, mean  SD 2.8  1.9 4.1  2.7 1.3 (1.03–1.6) .03
Number of blood culture days positive, mean  SD 3.7  5.9 2.7  3.3 1.0 (0.85–1.1) .48
Methicillin-resistant Staphylococcus aureus, n (%) 30 (55.6) 16 (72.7) 2.1 (0.7–6.3) .16
Echocardiogram not done, n (%) 19 (35.2) 15 (68.2) 3.9 (1.4–11.4) .008
Coronary Artery Disease, n (%) 36 (66.7) 14 (63.6) 0.9 (0.3–2.5) .80
Congestive heart failure, n (%) 16 (29.6) 11 (50) 2.4 (0.9–6.6) .09
Stroke, n (%) 9 (16.7) 7 (31.8) 2.3 (0.7–7.3) .14
Diabetes mellitus, n (%) 18 (33.3) 8 (36.4) 1.1 (0.4–3.2) .80
Acute renal insufficiency, n (%) 20 (37.0) 14 (63.6) 2.9 (1.1–8.3) .03
Chronic renal insufficiency, n (%) 13 (24.1) 8 (36.4) 1.8 (0.6–5.3) .28
Hemodialysis, n (%) 9 (16.7) 3 (13.6) 0.8 (0.2–3.2) 0.99
Enteral feeding, n (%) 8 (14.8) 5 (22.7) 1.7 (0.5–5.9) .50
Prior hospitalization, n (%) 24 (44.4) 13 (59.1) 1.8 (0.7–4.9) .25
Prior surgery, n (%) 15 (27.8) 7 (31.8) 1.2 (0.4–3.6) 0.72
Catheter associated, n (%) 11 (20.4) 3 (13.6) 0.6 (0.2–2.5) .75
Endocarditis, n (%) 5 (9.3) 2 (9.1) 0.9 (0.2–5.5) 0.99
Intravascular infection, n (%) 4 (7.4) 1(4.5) 0.6 (0.1–5.6) 0.99
Wound related, n (%) 11 (20.4) 5 (22.7) 1.1 (0.3–3.8) 0.99
Unknown source, n (%) 8 (14.8) 11 (50) 5.8 (1.9–17.7) .001
Respiratory tract, n (%) 6 (11.1) 0 (0.0) 0.7 (0.6–0.8) .17
Neither transesophageal nor transthoracic echocardiogram obtained.
SD 5 standard deviation.
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dwelling before admission, which probably increases the
possibility of occult endocarditis.13,14 The microbiology in
patients with unknown source did not differ from the over-
all cohort; 12 (63.2%) of the 19 had MRSA (vs 60.5%
overall). Regardless of possible misclassification bias, the
observed association between unknown source of SAB and
greater mortality warrants further investigation in larger,
prospective studies.
Perhaps more importantly, the diagnostic approach
to older adults with SAB should be examined critically.
Forty-five percent of patients did not undergo any type of
echocardiography in the setting of SAB. In general, trans-
esophageal echocardiography (TEE) is recommended for
patients with any blood culture positive for S. aureus to
excluded occult endocarditis,15 but TEE is an invasive pro-
cedure that requires sedation, anesthesia, or both, and some
clinicians may have perceived this testing as too aggressive
in this older cohort, particularly for patients who were felt
to have a poor prognosis overall. Alternatively, clinicians
may have had similar feelings in patients with short dura-
tions of SAB with a clearly identifiable source. Both of these
scenarios were noted in the patients who did not receive
TEEs. Low rates of transthoracic echo testing, which unlike
TEE, is a noninvasive test, were also observed.
Prospective evaluation should consider clinicians’ rea-
sons for ordering or not ordering TEE for older adults in the
setting of SAB. It remains unclear whether confirmation of a
diagnosis of endocarditis would affect clinical outcomes,
because definitive treatment with valve replacement surgery
also has significant operative risk.16 Elderly patients with
infective endocarditis have been noted to have lower rates
of surgical treatment and higher mortality than younger
patients.13 Alternatively, by excluding endocarditis, TEE
results might help clinicians select shorter durations of par-
enteral antimicrobial therapy with confidence, thus de-
creasing the risk of adverse events related to extended
courses of antistaphylococcal therapy and the extended
need for intravenous access. Although the reasons for not
obtaining echocardiography remains unclear, the results
may offer important prognostic information and thus help
establish overall goals of care in a population with a high
incidence of adverse events (including mortality).
The association of SAB with prior surgery or other in-
vasive procedures before SAB is another important obser-
vation. In these patients, the surgical intervention was
the source of SAB almost half of the time. Interventions
to decrease S. aureus–related surgical site infections (SSIs)
include preoperative screening and decolonization ef-
forts.17,18 Although larger studies have failed to show
consistent benefits of this strategy, older patients may
benefit with a modified version of this approach. Recent
work has demonstrated a strong association between
ADL impairment and MRSA SSIs.19 Although functional
status is generally not considered an absolute contraindi-
cation for surgery, the observation that even modest
impairment in ADLs can result in significant risk of
MRSA SSI (and consequently SAB) is notable.19 The asso-
ciation between SSI and SAB presents another important
area for future investigation, particularly with regard to
preventative strategies.20,21
Although MRSA is well recognized as an important
risk factor for death in patients with SAB,6,7,22,23 the results
of the current study failed to show such an association. The
lack of association probably reflects the large portion of
patients who had MRSA, the high rates of overall mortality,
or simply a Type II error due to a relatively small sample
size. Although no association was observed between base-
line functional status (independent vs requiring assistance
with ADLs) and mortality, earlier studies have clearly dem-
onstrated the relationship between poor functional status
and infection-related mortality.24,25 Detailed measures of
functional status should be recorded in future studies of
SAB to help further define the relationship between debility
and infection outcomes.
Although its retrospective design and small sample size
limited the present study, the results show significant in-
hospital and 6-month mortality in elderly patients with
SAB. There is also a possible association with recent sur-
geries or implantation of medical devices. The reasons why
clinicians did not pursue echocardiography evaluation in
this patient cohort are unclear but may reflect a belief that
the risks of TEE are perceived as too high in older adults.
Future investigation of SAB in older adults should focus on
preventative strategies, as well as diagnostic and treatment
paradigms, given the high morbidity and mortality associ-
ated with this infection.
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Table 4. Multivariate Analysis of the Association Be-
tween Select Patient Characteristics and In-Hospital Mor-
tality in Patients Aged 80 with Staphylococcus aureus
Bloodstream Infections
Characteristic
OR (95% CI) P-Value
Unadjusted Adjusted
MRSA 2.1 (0.7–6.3) .16 2.1 (0.6–7.2) .22
Unknown cause infection 5.8 (1.9–17.7) .001 5.2 (1.5–18.0) .008
Acute renal insufficiency 2.9 (1.1–8.3) .03 1.7 (0.5–5.7) .37
Charlson weighted index 1.3 (1.03–1.6) .03 1.2 (1.0–1.6) .10
Odds ratios (ORs) and 95% confidence intervals (CIs) are based on a mul-
tivariable logistic regression adjusting for methicillin-resistant S. aureus
(MRSA), infection from unknown cause, acute renal insufficiency, and
Charlson weighted index of comorbidity.
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